Mechanism of hemostasis defects and management of bleeding in patients with acute coronary syndromes
- 31 August 2010
- journal article
- review article
- Published by Elsevier BV in European Journal of Internal Medicine
- Vol. 21 (4), 254-259
- https://doi.org/10.1016/j.ejim.2010.03.010
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- New antiplatelet agents: Why they are neededEuropean Journal of Internal Medicine, 2009
- Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry dataThe Lancet, 2009
- Anemia, Hemorrhage, and Transfusion in Percutaneous Coronary Intervention, Acute Coronary Syndromes, and ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2009
- Clinical implications and management of bleeding events in patients with acute coronary syndromesJournal of Cardiovascular Medicine, 2009
- A new era for anticoagulantsEuropean Journal of Internal Medicine, 2009
- Prevention and Treatment of Major Blood LossNew England Journal of Medicine, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCell Metabolism, 2006
- Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non–ST-Segment Elevation Acute Coronary SyndromesJAMA, 2005
- Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary SyndromesThe American Journal of Cardiology, 2005
- Hemostatic DrugsNew England Journal of Medicine, 1998